Toru Harabayashi

Papers

1

Total Citations

27

H-Index

1

About

Toru Harabayashi is a leading urologic oncologist whose research focuses on advancing surgical treatments for bladder cancer, with a particular emphasis on cost-effectiveness and comparative outcomes. His major contributions center on systematic evaluations of radical cystectomy techniques—open, laparoscopic, and robot-assisted—providing critical insights into the economic implications of modern surgical approaches. His most cited work, a 2019 systematic review of segmental costs comparing these procedures, has garnered 27 citations, highlighting its relevance in an era of rising healthcare expenditures. Harabayashi’s research addresses a key gap in the literature by analyzing not just clinical efficacy but also the financial burdens associated with each method, offering valuable guidance for surgeons and policymakers. Beyond this, his broader portfolio includes studies on surgical complications, oncologic outcomes, and patient quality of life, cementing his reputation as a meticulous investigator dedicated to evidence-based urology. His work is particularly impactful for trainees and clinicians seeking to balance innovation with resource stewardship.

Research Focus

Key Achievements

1
H-Index
1
Papers
27
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Cost comparison between open radical cystectomy, laparoscopic radical cystectomy, and robot-assisted radical cystectomy for patients with bladder cancer: a systematic review of segmental costs
27 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 8

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago